BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Health Discovery Corporation 

6709 Waters Avenue

Savannah  Georgia  31406  U.S.A.
Phone: 800-965-3198 Fax: 912-598-8776


SEARCH JOBS




Industry
Biotechnology






 Company News
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation (DWCM.OB) 12/28/2012 6:49:28 AM
Health Discovery Corporation (DWCM.OB) Issues Corporate Update, CEO Resigns 10/23/2012 9:17:31 AM
Health Discovery Corporation (DWCM.OB) Launches Android Version of Popular MelApp, Melanoma Risk Analysis Mobile Phone App 2/1/2012 11:10:27 AM
NeoGenomics, Inc. (NGNM.OB) Enters Into Exclusive Worldwide Licensing Agreement With Health Discovery Corporation (DWCM.OB) 1/9/2012 11:28:02 AM
Health Discovery Corporation (DWCM.OB) Enters into Worldwide Licensing Agreement with NeoGenomics, Inc. (NGNM.OB) 1/9/2012 6:41:58 AM
Health Discovery Corporation (DWCM.OB) and Doctors Optimal Formula to Develop World’s First SVM-Based Retinal Image Analysis for Retinal Disease Assessment and Treatment Protocol 10/18/2011 10:37:43 AM
Health Discovery Corporation (DWCM.OB) Agrees with the U.S. Preventive Services Task Force's Position Against PSA-Based Screening for Prostate Cancer and Believes its Four-Gene Assay for Prostate Cancer is the Best Alternative to PSA 10/14/2011 9:55:21 AM
Health Discovery Corporation (DWCM.OB) Issues Update on U.S. and International Developments Relating to its SVM-RFE Technology Patents 10/7/2011 9:24:44 AM
Health Discovery Corporation (DWCM.OB) Issues Update on Developments Relating to Intel RFE-SVM Patent 10/6/2011 10:13:50 AM
Health Discovery Corporation (DWCM.OB) Announces Issuance of First Patent Covering Prostate Cancer Biomarkers 9/28/2011 9:55:43 AM
1234567